Group One Trading
TCRT icon

Group One Trading’s Alaunos Therapeutics TCRT Stock Holding History

Group One Trading’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-150
Closed -$1.05K – 7358
2024
Q2 		$1.05K Buy
+150
New +$1.79K ﹤0.01% 6351
2023
Q3 		– Sell
-251
Closed -$19.2K – 8294
2023
Q2 		$19.2K Buy
251
+3
+1% +$243 ﹤0.01% 6016
2023
Q1 		$23.4K Sell
248
-14
-5% -$1.33K ﹤0.01% 5401
2022
Q4 		$25.5K Sell
262
-1,012
-79% -$147K ﹤0.01% 5457
2022
Q3 		$329K Buy
1,274
+15
+1% +$4.36K ﹤0.01% 3647
2022
Q2 		$234K Buy
1,259
+324
+35% +$31K ﹤0.01% 4141
2022
Q1 		$92K Sell
935
-36
-4% -$4.62K ﹤0.01% 5568
2021
Q4 		$159K Sell
971
-224
-19% -$49.2K ﹤0.01% 5307
2021
Q3 		$326K Buy
1,195
+261
+28% +$79.8K ﹤0.01% 4657
2021
Q2 		$370K Buy
934
+17
+2% +$7.93K ﹤0.01% 4555
2021
Q1 		$495K Sell
917
-626
-41% -$390K ﹤0.01% 4045
2020
Q4 		$583K Buy
1,543
+806
+109% +$320K ﹤0.01% 3138
2020
Q3 		$279K Sell
737
-60
-8% -$26.5K ﹤0.01% 3379
2020
Q2 		$392K Sell
797
-230
-22% -$103K ﹤0.01% 2835
2020
Q1 		$377K Sell
1,027
-2,061
-67% -$1.07M ﹤0.01% 2251
2019
Q4 		$2.19M Sell
3,088
-305
-9% -$210K 0.01% 1222
2019
Q3 		$2.18M Buy
3,393
+725
+27% +$575K 0.02% 1148
2019
Q2 		$2.33M Buy
2,668
+739
+38% +$508K 0.02% 967
2019
Q1 		$1.11M Sell
1,929
-260
-12% -$109K 0.01% 1332
2018
Q4 		$614K Sell
2,189
-448
-17% -$177K 0.01% 1866
2018
Q3 		$1.27M Sell
2,637
-32
-1% -$13.7K 0.01% 1507
2018
Q2 		$1.21M Buy
2,669
+1,036
+63% +$657K 0.01% 1535
2018
Q1 		$960K Sell
1,633
-574
-26% -$358K 0.01% 1551
2017
Q4 		$1.37M Buy
2,207
+306
+16% +$220K 0.01% 1455
2017
Q3 		$1.75M Sell
1,901
-300
-14% -$266K 0.02% 1146
2017
Q2 		$2.05M Buy
2,201
+329
+18% +$323K 0.02% 937
2017
Q1 		$1.78M Sell
1,872
-1,382
-42% -$1.29M 0.02% 943
2016
Q4 		$2.61M Buy
3,254
+599
+23% +$540K 0.03% 776
2016
Q3 		$2.24M Sell
2,655
-1,334
-33% -$1.07M 0.02% 789
2016
Q2 		$3.29M Buy
3,989
+1,264
+46% +$1.38M 0.04% 564
2016
Q1 		$3.03M Sell
2,725
-1,149
-30% -$1.18M 0.04% 564
2015
Q4 		$4.83M Sell
3,874
-205
-5% -$339K 0.06% 389
2015
Q3 		$5.51M Sell
4,079
-1,342
-25% -$2.21M 0.08% 326
2015
Q2 		$9.76M Buy
5,421
+995
+22% +$1.54M 0.14% 155
2015
Q1 		$7.15M Buy
4,426
+2,546
+135% +$3.77M 0.11% 160
2014
Q4 		$1.43M Buy
1,880
+189
+11% +$100K 0.02% 839
2014
Q3 		$670K Sell
1,691
-171
-9% -$82.4K 0.01% 1397
2014
Q2 		$1.13M Buy
1,862
+151
+9% +$84.1K 0.02% 1057
2014
Q1 		$1.18M Sell
1,711
-1,072
-39% -$718K 0.02% 969
2013
Q4 		$1.81M Buy
2,783
+1,407
+102% +$838K 0.03% 705
2013
Q3 		$815K Sell
1,376
-103
-7% -$46.4K 0.02% 1173
2013
Q2 		$466K Buy
+1,479
New +$411K 0.01% 1411

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Group One Trading's TCRT Position: Q3 2025 in Review

Group One Trading sold out of Alaunos Therapeutics (TCRT) in Q3 2025, closing a stake of 300 shares — an estimated $1.46K sold.

Group One Trading first reported a position in TCRT in Q2 2013 and held it in 48 quarters. The position peaked at $4.96M in Q2 2015. 26 funds tracked by Wall St. Rank hold TCRT as of Q3 2025.

  • Group One Trading reported no remaining Alaunos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 300 Alaunos Therapeutics shares in Q3 2025, an estimated $1.46K.
  • Group One Trading first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 48 quarters.
  • Group One Trading's Alaunos Therapeutics position peaked at $4.96M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.